Affiris

AFFiRiS is an innovative biotechnology company developing first-in-class antigen-specific vaccines for the prevention and treatment of chronic illnesses.

Using its proprietary AFFITOME® technology, AFFiRiS is able to develop customized peptide-based vaccines targeting Alzheimer’s disease, Parkinson’s disease, atherosclerosis, diabetes, and other diseases with unmet medical needs.